WHO ICTRP trial
The effect of doxium on retial thickness in diabetic patients
IRCT2012091610852N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2012091610852N1 |
|---|---|
| Public title | The effect of doxium on retial thickness in diabetic patients |
| Scientific title | The effect of oral calcium dobisulate (doxium) on macular thickness in diabetic retinopathy and clinicaly significant macular edema(CSME) |
| Primary sponsor | Ahvaz Jundishapur University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Diabets melitus. Diabetic retinopathy;Diabetic retinopathy |
| Interventions | Intervention 1: calcium dobisulate (doxium) capsules 500 mg,oraly , three times in one day for three months. Intervention 2: Placebo capsules, orally ,three times daily for three months.;Treatment - Drugs;Placebo;calcium dobisulate (doxium)… |
| Registration date | Apr 21, 2013 |
| Target size | 40 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: